Cyproterone acetate - Transgender Health - adults

You are here : Home > Formulary Search > Cyproterone acetate - Transgender Health - adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Documentation

Education material (for healthcare personnel)

Gender Identity Training and Information Resources

PAD Profile

ChemicalSubstance :

Cyproterone acetate

Indication :

Transgender Health - adults

Group Name :

Keywords :

gender reassignment, gender re-assignment, gender identity clinics, GICs, gender incongruence, sex change, transgender, hormonal therapy, feminisation, transsexuals, hormonal treatment, hirsutism, gender dysphoria

Brand Names Include :

Androcur

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Transgender Health - adults

Supporting Documents :

Other Indications

Below are listed other indications that Cyproterone acetate is used to treat.

Prostate cancer

Other Drugs

Below are listed other drugs that are used to treat Transgender Health - adults.

Committee Recommendations (1)

06 Dec 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

After undertaking a review of previous decisions and resources relating to transgender health, the APC agreed an AMBER status for oestrogen, testosterone, cyproterone, finasteride, GnRH & medroxyprogeterone when used in adults.

Primary care initiation of these drugs is supported by the APC if the prescriber is competent to exercise their share of clinical responsibility and is assured that the shared care protocol provides enough information for them to discharge their responsibilities safely.

A guide to support primary care prescribing for people who access gender identity services was also agreed by the APC.

The guide includes information on children and young people, requests to prescribe, shared care, on-going care and private providers.